Posts

Bortenat 3.5mg Injection ( Natco )

DESCRIPTION  Bortezomib is a drug sold under the brand name of Bortenat 3.5mg which belongs to anti-neoplastic medicine, the main ingredient which is used as bortenat, which is available in the form of lyophilized powder Bortenat 3.5mg is a prime benign proteasome inhibitor; proteasome is a biological structure that clefts the proteins Pharmacological grouped as an anti-neoplastic agent or proteasome inhibitor The drug is a prescription drug given under the supervision of pharmacist INDICATIONS Bortenat 3.5mg is majorly indicated for the treatment for patients suffering from the following disease. Multiple myeloma Mantle cell lymphoma MECHANISM OF ACTION The drug Bortenat is a type of chymotrypsin-like activity which is in the form of unstable prohibition of the 26S proteasome in human cells. The 26S proteasome is a group of protein that reduces the agglutinated proteins The various proteins are weakened by proteasome enzymes that make difficult to tumor cells persistence lik
Post a Comment
Read more

BORTENAT 2MG INJECTION ( NATCO )

DESCRIPTION  Bortezomib is a drug sold under the brand name of Bortenat 2mg which belongs to anti-neoplastic medicine, the main ingredient which is used as bortenat, which is available in the form of lyophilized powder Bortenat 2mg is a prime benign proteasome inhibitor; proteasome is a biological structure that clefts the proteins Pharmacological grouped as anti-neoplastic agent or proteasome inhibitor The drug is a prescription drug given under the supervision of pharmacist INDICATIONS Bortenat 2mg is majorly indicated for the treatment for patients suffering from the following disease. Multiple myeloma Mantle cell lymphoma MECHANISM OF ACTION The drug Bortenat is a type of chymotrypsin-like activity which is in the form of unstable prohibition of the 26S proteasome in human cells. The 26S proteasome is a group of protein that reduces the agglutinated proteins The various proteins are weakened by proteasome enzymes that make difficult to tumor cells persistence like cyclins
Post a Comment
Read more

Rolimus 5mg tablet - Everolimus | Myapplepharma

DESCRIPTION Rolimus 5mg belongs to a class of anti-cancer drugs Rolimus 5mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Rolimus 5mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Rolimus 5mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Rolimus 5mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. MECHANISM Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Rolimus also prohibits the expression of hypoxia-inducible factor
Post a Comment
Read more

Rolimus 10mg tablet - Everolimus | Myapplepharma

DESCRIPTION Rolimus 10mg belongs to the class of anti-cancer drugs Rolimus 10mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Rolimus 10mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Rolimus 10mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Rolimus 10mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. MECHANISM Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Rolimus also prohibits the expression of hypoxia-inducible
Post a Comment
Read more

Rapact 5mg tablet - Everolimus | Myapplepharma

DESCRIPTION  Rapact 5mg belongs to a class of anti-cancer drugs. Rapact 5mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Rapact 5mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Rapact 5mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Rapact 5mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. MECHANISM Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Rapact also prohibits the expression of hypoxia-inducible factor, cau
Post a Comment
Read more

Rapact 10mg tablet - Everolimus | Myapplepharma

DESCRIPTION  Rapact 10mg  belongs to the class of anti-cancer drugs. Rapact 10mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Rapact 10mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Rapact 10mg is mainly used for the treatment of the following disease • kidney carcinoma • Breast carcinoma • Brain carcinoma Rapact 10mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. MECHANISM Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis. Rapact also prohibits the expression of hypoxia-inducible fac
Post a Comment
Read more

Everotas 10mg tablet - Everolimus | Myapplepharma

DESCRIPTION Everotas 10mg belongs to the class of anti-cancer drugs Everotas 10mg contains an active compound known as Everolimus which interferes with the development of cancer cell and the process is slowed down. Everotas 10mg tablets is not a curable medication, which helps to slow their spreading into the body. PRESCRIBED FOR The drug Everotas 10mg is mainly used for the treatment of the following disease. • kidney carcinoma • Breast carcinoma • Brain carcinoma Everotas 10mg is also used to treat in various advanced stage cancer in stomach, intestines or pancreas. CLINICAL PHARMACOLOGY OF EVEROTAS Everolimus is a prohibition of mTOR, links at peak compatibility to FK506 binding protein 12, through producing drug complex which prevents the productive of mTOR. This inhibition reduces the activity of effectors downstream, which may lead to stoppage of cell progression from G1 into S phase, finally causes cell growth arrest and apoptosis.Everotas also prohibits the e
Post a Comment
Read more